Healthcare Market Research Expert

Commercialization of Safe and Cost-Effective Heparin Products Drives the Global Heparin Market

Press Release   •   Feb 07, 2017 07:35 EST

Heparin is an anticoagulant that is primarily used to prevent and treat venous thrombosis, pulmonary embolism, and other conditions of blood clotting. This report provides in-depth analysis of the global heparin market. Stakeholders for this report include manufacturers of heparin products, crude heparin suppliers, heparin processing companies, and new players planning to enter the market.

Download Exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=803

The global heparin market has been studied from two perspectives: by products and by geography. The heparin market, by products, comprises unfractionated heparin, low molecular weight heparin, and ultra-low molecular weight heparin. A detailed market analysis and forecast for each of these segments have been provided in this study in terms of market revenue (USD million) for the period from 2013 to 2023.

The report also provides compounded annual growth rate (CAGR %) for each of these segments for the forecast period from 2015 to 2023, considering 2013 and 2014 as historical and base years, respectively. Furthermore, the heparin market, by geography, includes North America, Europe, Asia Pacific, and Rest of the World. Each of these regions has been sub-segmented and analyzed for major contributing countries.

The market overview section of the report demonstrates major market dynamics such as drivers, restraints and opportunities that influence the current and future status of this industry. The market overview section includes Porter’s Five Forces Analysis and market attractiveness analysis by geography coupled with qualitative analysis on regulatory scenarios, impact analysis of key industry events, and value chain analysis to provide a thorough analysis of the overall competitive scenario in the global heparin market. The market overview section of the report also includes the qualitative and quantitative analysis of the competitive landscape.

Market share analysis is also provided in the market overview section of the report for 2014 in terms of value (%). The report also provides important recommendations for market players and new entrants. These recommendations would enable existing market players to expand their market share and help new companies establish their presence in the heparin market in Europe.

The report concludes with the company profiles section, which includes key information about major players in the market such as financial overview, business strategies, and recent developments. Key players mentioned in the report include Dr. Reddy's Laboratories Ltd., Fresenius Kabi AG, LEO Pharma A/S, Mylan N.V., Pfizer, Inc., Sanofi S.A., Syntex S.A., and Teva Pharmaceutical Industries Ltd.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.